RAMM Pharma Corp. engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland. It offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products, as well as resells medical supplies products; and sells medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
Metrics to compare | RAMM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRAMMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −2.2x | −0.5x | |
PEG Ratio | 0.01 | 0.00 | 0.00 | |
Price/Book | 0.2x | 0.7x | 2.6x | |
Price / LTM Sales | 0.8x | 0.8x | 3.3x | |
Upside (Analyst Target) | - | 75.7% | 47.1% | |
Fair Value Upside | Unlock | 21.1% | 5.8% | Unlock |